Cite
HARVARD Citation
Doubek, M. et al. (n.d.). Ofatumumab added to dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia: Results from a phase II study. American journal of hematology. 90 (5), pp. 417-421. [Online].